Ascent Scientific Expands Low-Cost Ligand™ Glutamate Range to Help Research into Neurological Disorders

Share Article

Ascent Scientific (http://www.ascentscientific.com) announced the expansion of its Low-Cost Ligand ™ glutamate range – chemical tools that will aid research into a wide range of neurological disorders. The range includes groundbreaking research tools such as Fenobam, MTEP, and YM-298198 and will aid research into disorders such as anxiety, pain, Alzheimers, epilepsy and stress-related conditions.

Ascent Scientific expands Low-Cost Ligand™ glutamate range, to help research into neurological disorders.

Ascent Scientific (http://www.ascentscientific.com) announced the expansion of its Low-Cost Ligand ™ glutamate range – chemical tools that will aid research into a wide range of neurological disorders. The range includes groundbreaking research tools such as Fenobam, MTEP, and YM-298198 and will aid research into disorders such as anxiety, pain, Alzheimers, epilepsy and stress-related conditions.

Steve Roome PhD, Commercial Director commented, “Our newly expanded range includes exciting new research tools such as Fenobam, MTEP and the novel YM-298198, which is currently only available from Ascent Scientific. In addition, we have introduced a range of popular standard tools including CNQX and MK-801. The expanded Low-Cost Ligand™ glutamate range is particularly special, as the tools are offered at prices up to 50% less than other suppliers – in keeping with our philosophy to make research tools affordable for as many researchers as possible.”

About Ascent Scientific

Ascent Scientific provides high quality receptor ligands, synthetic chemistry, research, consultancy and analytical services for life science, pharmaceutical and chemistry-related industries.

The Low-Cost Ligand™ range includes glutamate, histamine, purinergic and vanilloid receptor ligands together with signalling tools. The glutamate range includes:

  •     AMN082: the first selective mGlu7 agonist
  •     D-AP5: Potent selective NMDA antagonist
  •     L-AP4: selective group III mGlu agonist
  •     CNQX: AMPA/Kainate receptor antagonist
  •     Fenobam: novel mGlu5 antagonist
  •     (+)-MK 801: potent, selective NMDA antagonist
  •     MTEP: brain penetrant, selective mGlu5 antagonist
  •     MPEP: mGlu5 selective antagonist
  •     YM298198: potent, selective mGlu1 antagonist

Contact:

Steve Roome, Commercial Director +44 (0)1934 624 695

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Steve Roome